Effectiveness and safety of monthly versus quarterly fremanezumab for migraine prevention: An Italian, multicenter, real-life study.
Laura ZanandreaRoberta MessinaIlaria CettaFederica GenoveseSimone GuerrieriFabrizio VernieriClaudia AltamuraSabina CevoliValentina FavoniBruno ColomboMassimo FilippiPublished in: European journal of neurology (2024)
Both monthly and quarterly regimens were effective and safe, with a tendency for an advantage of the monthly regimen only in the first quarter of treatment.